Module 1 Flashcards

1
Q

bacteria were discovered to be capable of being infected by viruses. The bacterial invaders were called

A

Bacteriophages / phages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In what year does bacteria were discovered to be capable of being infected by viruses.

A

1915

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The concept behind modern virology can be traced back to who, independently in the late 1880’s, discovered what was later to be called tobacco mosaic virus (TMV).

A

Adolf Mayer
Dimitri Ivanofsky
Martinus Beijerinck

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The first filterable agent from animals, foot and mouth disease virus, was described by ____ and ___. What year was it discovered?

A

Loeffler
Frosch
1898

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

first human filterable agent discovered was called

A

Yellow fever virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

first human filterable agent or yelloe fever virus was discovered by _____ and what year?

A

Walter Reed

1901

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The term ‘virus’ derives from the Latin word _______.

A

Slimy liquid / poison

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The first term for the virus is ________.

A

Filterable agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The first virus to be visualized by x-ray crystallography and electron microscopy was

A

TMV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The two people who worked independently, are credited with the discovery of viruses which could infect and lyse bacteria. Year?

A

Frederick Twort
Felix d’Herelle
1941 and 1939

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Who introduced the term ‘bacteriophages’ for these agents and also described the concepts of virus adsorption to its target, cell lysis and release of infectious particles.

A

Felix d’Herelle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

An infectious agent composed of nucleic acid (RNA or DNA), a protein shell (capsid) and, in some cases, a lipid envelope.

A

VIRUS PARTICLE OR VIRION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

It has a full capacity for replication when a susceptible target cell is encountered.

A

Virion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The protein coat that surrounds the viral nucleic acid.

A

Capsid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Capsid are composed of repeating protein MID 29 subunits called

A

Capsomeres

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The complete protein-nucleic acid complex.

A

Nucleocapsid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Viruses which require a second virus (helper virus) for replication.

A

SATELLITE OR DEFECTIVE VIRUSES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

It is an example of defective virus that requires the presence of hepatitis B virus to complete its replication cycle.

A

Hepatitis D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

smallest known autonomously replicating molecules. They consist of single- stranded, circular RNA, 240-375 residues in length and are plant pathogens.

A

Viroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

not viruses but are often discussed within this microbiologic category.

A

Prions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

It is an infectious protein molecules that contain no definable nucleic acid and are responsible for the transmissible and familial spongiform encephalopathies

A

Prions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The pathogenic prion protein that is formed from a normal human protein, PrPC , through post-translational processing

23
Q

Modern classification is based on what characteristics.

A

A. Type of viral nucleic acid (RNA or DNA, single- stranded or double-stranded) and its replication strategy.

B. Capsid symmetry (icosahedral or helical).

C. Presence or absence of lipid envelope.

D. Structure

24
Q

What are the four different viral capsid shape?

A

Helical
Polyhedral
Spherical
Complex

25
ssDNA - nonenveloped
Parvoviridae
26
dsDNA - enveloped
Poxviridae Herpesviridae Hepadnaviridae
27
dsDNA - nonenveloped
Adenoviridae | papillomaviridae
28
dsDNA - enveloped that replicates through an RNA intermediate
Hepadnaviridae
29
dsRNA - nonenveloped
Reoviridae
30
ssRNA - (-) strand - enveloped
``` Filoviridae Bunyaviridae Rhabdoviridae Orthomyxoviridae Paramyxoviridae Arenaviridae ```
31
ssRNA - (+) strand - enveloped
Togaviridae Flaviviridae Coronaviridae Retroviridae
32
ssRNA - (+) strand - nonenveloped
Picornaviridae | Caliciviridae
33
The seven (7) several stages are?
1. Attachment 2. Entry 3. Uncoating 4. Replication 5. Assembly 6. Release ``` According to the picture: Attachment Penetration Uncoating Release Assembly Biosynthesis ```
34
The virus becomes attached to the cell by specific cellular receptors which can be glycoproteins, phospholipids or glycolipids.
Attachment
35
Following attachment the virus can enter the cell, most commonly via receptor mediated endocytosis. This is the same process by which many hormones enter the cell.
Entry
36
Once inside the host cell, the viral capsid must be uncoated to release the viral nucleic acid. Uncoating may be achieved by host or viral enzymes that will degrade the capsid.
Uncoating
37
Once uncoated, viruses (DNA or RNA) replicate by switching the host machinery from cellular protein synthesis to viral synthesis and viral proteins are produced.
Replication
38
Newly synthesised viral proteins are post-transcriptionally modified and packaged into virions that can be released from the infected host cell to infect other cells.
Assembly
39
Virions are released from the cell either by lysis or budding. In lysis, the infected cell dies and the virions are released. In budding, the virion takes some of the host cell’s membrane with it as it leaves – this normally does not kill the infected cell.
Release
40
Explain the Selection of Specimens
The specimen should be collected from the target organ most closely associated with clinical symptoms to identify the etiologic agent responsible for the patient's disease.
41
What reagent prevents the specimen drying, maintains viral viability and retards the growth of microbial contaminants.
VTM | Viral Transport Medium
42
What VTM contains?
VTM contains gelatin and antimicrobial agents in a buffered salt solution.
43
What supplies do you use for certain samples such as urethral swabs?
Sterile cotton | Dacron or rayon-tipped swabs with plastic or aluminum shafts small-tip flexible (fine- shafted aluminum) swabs
44
What supplied to be used for aspirating vesicular fluid?
Tuberculin syringe with 26- or 27-gauge needle
45
What supplies to be used for blood?
Blood collection tubes containing anticoagulant (ACD) | -yellow top
46
What swabs should not be used?
Alginate swabs or wooden-shafted swabs
47
Specimen preparation for throat wash
The patient gargles with 10 mL of sterile balanced salt solution (Hank's or Earles BSS) or trypticase soy broth (TSB); expelled into a sterile container.
48
Specimen preparation for Urine
Random clean catch sample | collected in a sterile container.
49
Specimen preparation for Blood
Collect 7-10 mL of blood in a Yellow ACD tube (Solution A or B). Blood more than 72 hrs old from time of collection to the time of processing will be rejected.
50
Specimen preparation for Naso-pharyngeal swab
Insert a flexible fine-shafted swab through the nostril into the nasopharynx and rotate swab gently a few times. Place into M4 viral transport media.
51
Specimen preparation for vesicle fluids
Withdraw vesicle fluid using a tuberculin syringe or swab the vesicle and place it in an M4 Culture Transport Tube or 1 ml of BSS or TSB; crusted, dry lesions are not vesicles and are not appropriate for virus isolation.
52
Specimen preparation for tissue
Collect aseptically and keep moist by placing in sterile container with 2 mL of BSS (Hanks Phosphate Buffered Saline), TSB, saline or viral transport media M4.
53
Specimen preparation for stool
Approximately 5 gm of stool placed in a tightly-capped sterile container without preservatives. A swab covered with stool is acceptable for culture but not preferred. Swabs are UNACCEPTABLE for Clostridium difficile toxin.